Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Latest News about EXEL

Recent news which mentions EXEL

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
European Medicines Agency's CHMP Backs Approval Of Cabometyx/Opdivo Combo In Kidney Cancer
Tickers BMY EXEL IPSEF IPSEY
Tags General IPSEY IPSEF
From Benzinga
Exelixis' Cabozantinib Gets Breakthrough Therapy Status In Differentiated Thyroid Cancer
Tickers EXEL
Tags General Benzinga News
From Benzinga
Got $500? 3 Smart Stocks You Can Buy Right Now
Tickers EXEL JUSHF SBUX
Tags Market News EXEL SBUX
From Motley Fool
Exelixis' Cabozantinib Shows Overall Objective Response Rates of 38% In Genitourinary Tumor Settings
Tickers BMY EXEL
Tags Phase 1 Trial Biotech Market News
From Benzinga
Exelixis' Cabozantinib Data Shows Clinically Significant Benefit Versus Pfizer's Sutent, In A Type Of Kidney Cancer
Tickers BMY EXEL PFE
Tags Kidney Cancer Market News PFE
From Benzinga
Exelixis Inc (EXEL) Q4 2020 Earnings Call Transcript
Tickers EXEL
Tags EXEL Market News
From Motley Fool
Recap: Exelixis Q4 Earnings
Tickers EXEL
Tags Market News Earnings Benzinga
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
Tickers ABCL AEMD AGIO AMRX
Tags General IBB RDUS
From Benzinga
Earnings Scheduled For February 10, 2021
Tickers ACLS AEIS AEMD AIN
Tags ACLS IVC QLYS
From Benzinga
Earnings Outlook For Exelixis
Tickers EXEL
Tags BZI/EP EXEL Market News
From Benzinga
Opdivo Plus Cabometyx Combo Shows Superior Clinical Benefit Versus Sunitinib In Late-Stage Kidney Cancer Study
Tickers BMY EXEL PFE
Tags Benzinga BMY News
From Benzinga
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Tickers ABEO AEMD AGTC ALKS
Tags VERU VNDA DNLI
From Benzinga
Got $4,000? 4 Growth Stocks Begging to Be Bought
Tickers ALXN AZN DDOG EVER
Tags ALXN DDOG EVER
From Motley Fool
Exelixis Gets FDA Approval for Cabometyx in Combination Therapy for Front-Line RCC
Tickers BMY EXEL
Tags BMY EXEL Market News
From Motley Fool
5 Mid-Cap Stocks That'll Make You Richer in 2021
Tickers CRLBF EXEL PING SSRM
Tags EXEL Market News WTM
From Motley Fool
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
Tickers BLUE BMY EXEL
Tags BMY EXEL BLUE
From Motley Fool
Who's Ready to Get Rich? 5 Moneymaker Stocks to Buy Now
Tickers EXEL FSLY ISRG OGI
Tags Market News FSLY EXEL
From Motley Fool
3 Top Biotech Picks for 2021
Tickers BMY CRSP EXEL NVAX
Tags BMY RDY EXEL
From Motley Fool
5 Value Stocks That Will Make You Richer in 2021
Tickers AUY EXEL TEVA WBA
Tags WBA TEVA EXEL
From Motley Fool
Why Calithera Biosciences Stock Is Plunging Today
Tickers CALA EXEL
Tags Market News CALA EXEL
From Motley Fool
3 Healthcare Stocks That Are Screaming Buys in 2021
Tickers EXEL JUSHF TDOC
Tags TDOC Market News JUSHF
From Motley Fool
3 Beaten-Down Growth Stocks That Can Soar in 2021
Tickers EXEL PING VRTX
Tags PING VRTX EXEL
From Motley Fool
Should Investors Consider This Biotech Takeover Target?
Tickers ALXN AZN BMY EXEL
Tags Market News IMMU AZN
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
Tickers BMY CRSP EXEL NVAX
Tags Market News NVAX CRSP
From Motley Fool
Should Investors Buy Moderna Stock for Its Coronavirus Vaccine?
Tickers BMRN EXEL MRNA SGEN
Tags EXEL BMRN SGEN
From Motley Fool
Got $50? 4 Smart Stocks to Buy Into Right Now
Tickers AUY EXEL JUSHF SIRI
Tags EXEL AUY JUSHF
From Motley Fool
12 Healthcare Stocks Moving In Thursday's After-Market Session
Tickers ACRX BMRN CBAY CEMI
Tags General CEMI CHRS
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Tickers ABT ABUS ACAD ACRX
Tags Benzinga CRDF News
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Tickers ABUS ACAD ACOR ACRX
Tags AERI JAZZ ANIP
From Benzinga
The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings
Tickers ARPO ATXI BEAM BIIB
Tags LLY ATXI OPNT
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.